232 related articles for article (PubMed ID: 31761726)
1. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
[TBL] [Abstract][Full Text] [Related]
2. Advances in the discovery of N-acylethanolamine acid amidase inhibitors.
Bandiera T; Ponzano S; Piomelli D
Pharmacol Res; 2014 Aug; 86():11-7. PubMed ID: 24798679
[TBL] [Abstract][Full Text] [Related]
3. Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.
Petracca R; Ponzano S; Bertozzi SM; Sasso O; Piomelli D; Bandiera T; Bertozzi F
Eur J Med Chem; 2017 Jan; 126():561-575. PubMed ID: 27915171
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure-activity, and structure-stability relationships of 2-substituted-N-(4-oxo-3-oxetanyl) N-acylethanolamine acid amidase (NAAA) inhibitors.
Vitale R; Ottonello G; Petracca R; Bertozzi SM; Ponzano S; Armirotti A; Berteotti A; Dionisi M; Cavalli A; Piomelli D; Bandiera T; Bertozzi F
ChemMedChem; 2014 Feb; 9(2):323-36. PubMed ID: 24403170
[TBL] [Abstract][Full Text] [Related]
5. 3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.
Fiasella A; Nuzzi A; Summa M; Armirotti A; Tarozzo G; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
ChemMedChem; 2014 Jul; 9(7):1602-14. PubMed ID: 24828120
[TBL] [Abstract][Full Text] [Related]
6. Design and Structure-Activity Relationships of Isothiocyanates as Potent and Selective
Malamas MS; Pavlopoulos S; Alapafuja SO; Farah SI; Zvonok A; Mohammad KA; West J; Perry NT; Pelekoudas DN; Rajarshi G; Shields C; Chandrashekhar H; Wood J; Makriyannis A
J Med Chem; 2021 May; 64(9):5956-5972. PubMed ID: 33900772
[No Abstract] [Full Text] [Related]
7. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D
Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.
Ponzano S; Bertozzi F; Mengatto L; Dionisi M; Armirotti A; Romeo E; Berteotti A; Fiorelli C; Tarozzo G; Reggiani A; Duranti A; Tarzia G; Mor M; Cavalli A; Piomelli D; Bandiera T
J Med Chem; 2013 Sep; 56(17):6917-34. PubMed ID: 23991897
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds.
Li Y; Yang L; Chen L; Zhu C; Huang R; Zheng X; Qiu Y; Fu J
PLoS One; 2012; 7(8):e43023. PubMed ID: 22916199
[TBL] [Abstract][Full Text] [Related]
10. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C
Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121
[TBL] [Abstract][Full Text] [Related]
11.
Piomelli D; Scalvini L; Fotio Y; Lodola A; Spadoni G; Tarzia G; Mor M
J Med Chem; 2020 Jul; 63(14):7475-7490. PubMed ID: 32191459
[No Abstract] [Full Text] [Related]
12. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.
Solorzano C; Zhu C; Battista N; Astarita G; Lodola A; Rivara S; Mor M; Russo R; Maccarrone M; Antonietti F; Duranti A; Tontini A; Cuzzocrea S; Tarzia G; Piomelli D
Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20966-71. PubMed ID: 19926854
[TBL] [Abstract][Full Text] [Related]
13. Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology.
Lamani M; Malamas MS; Farah SI; Shukla VG; Almeida MF; Weerts CM; Anderson J; Wood JT; Farizatto KLG; Bahr BA; Makriyannis A
Bioorg Med Chem; 2019 Dec; 27(23):115096. PubMed ID: 31629610
[TBL] [Abstract][Full Text] [Related]
14. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.
Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG
Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639
[TBL] [Abstract][Full Text] [Related]
15. A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation.
Ribeiro A; Pontis S; Mengatto L; Armirotti A; Chiurchiù V; Capurro V; Fiasella A; Nuzzi A; Romeo E; Moreno-Sanz G; Maccarrone M; Reggiani A; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
ACS Chem Biol; 2015 Aug; 10(8):1838-46. PubMed ID: 25874594
[TBL] [Abstract][Full Text] [Related]
16. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.
Fotio Y; Ciccocioppo R; Piomelli D
Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452
[TBL] [Abstract][Full Text] [Related]
17. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
Jin W; Yang L; Yi Z; Fang H; Chen W; Hong Z; Zhang Y; Zhang G; Li L
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32326173
[TBL] [Abstract][Full Text] [Related]
18. Ramulus Cinnamomi essential oil exerts an anti-inflammatory effect on RAW264.7 cells through N-acylethanolamine acid amidase inhibition.
Jia W; He X; Jin W; Gu J; Yu S; He J; Yi Z; Cai B; Gao H; Yang L
J Ethnopharmacol; 2023 Dec; 317():116747. PubMed ID: 37311500
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.
Tuo W; Leleu-Chavain N; Spencer J; Sansook S; Millet R; Chavatte P
J Med Chem; 2017 Jan; 60(1):4-46. PubMed ID: 27766867
[TBL] [Abstract][Full Text] [Related]
20. Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
Migliore M; Pontis S; Fuentes de Arriba AL; Realini N; Torrente E; Armirotti A; Romeo E; Di Martino S; Russo D; Pizzirani D; Summa M; Lanfranco M; Ottonello G; Busquet P; Jung KM; Garcia-Guzman M; Heim R; Scarpelli R; Piomelli D
Angew Chem Int Ed Engl; 2016 Sep; 55(37):11193-11197. PubMed ID: 27404798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
